Savara, Inc. SVRA
NASDAQ · United States · Health Technology
$5.11-0.05 (-0.97%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.16 | -0.14 | -12.3% | $0 | — | -0.5%$5.73→$5.70 |
| Q1 2026 | 2026-05-12 | -0.15 | -0.14 | -7.1% | — | — | +2.9%$5.12→$5.27 |
| Q4 2025 | 2026-03-13 | -0.13 | -0.12 | -8.3% | — | — | -1.7%$5.32→$5.23 |
| Q3 2025 | 2025-11-12 | -0.14 | -0.13 | -7.7% | — | — | -1.6%$4.33→$4.26 |
| Q2 2025 | 2025-08-13 | -0.14 | -0.12 | -16.7% | — | — | — |
| Q1 2025 | 2025-05-13 | -0.12 | -0.13 | +7.7% | — | — | — |
| Q4 2024 | 2025-03-27 | -0.13 | -0.11 | -18.2% | — | — | — |
| Q2 2024 | 2024-08-12 | -0.12 | -0.11 | -9.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.